As of 2025-07-06, the Fair Value of Vanda Pharmaceuticals Inc (VNDA) is -3.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.97 USD, the upside of Vanda Pharmaceuticals Inc is -175.54%.
With the market price of 4.97 USD and our fair value calculation, Vanda Pharmaceuticals Inc (VNDA) is not a good investment. Investing in VNDA stocks now will result in a potential loss of 175.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 23.30 | 33.20 | 6.30 | 2.51 | -18.90 | 9.28 |
| YoY growth | -79.84% | 42.49% | -81.02% | -60.17% | -853.29% | -206.37% |
| Market Cap (mil) | 292.88 |
| P/E | |
| Forward P/E |
| EPS | -0.75 |
| Avg earnings growth rate | -206.37% |
| TTM earnings | -44.25 |